Niels Wcj van de Donk

41PUBLICATIONS
158CO-AUTHORS
Medical mycologyHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Aug 13, 2026
Clinical outcomes of newly diagnosed myeloma patients with SLIM criteria : a subgroup analysis of the CASSIOPEIA study.

|Jun 23, 2026
Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients.

|Apr 20, 2026
Monocyte-mediated metabolic rewiring via CD31-CD38 interactions promotes growth and drug-resistance in multiple myeloma.

|Apr 06, 2026
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.

Francesca Gay, Wilfried Roeloffzen, Meletios A Dimopoulos

|Feb 20, 2026
Immunoglobulin supplementation and longer dosing intervals reduce risk of infections in patients with RRMM treated with teclistamab.

Febe Smits, Kaz Groen, Charlotte L B M Korst

|Jan 04, 2026
Efficacy and safety of teclistamab in triple-class exposed relapsed/refractory multiple myeloma: Pooled findings from three clinical cohorts and a retrospective cohort.

Thomas G Martin, María-Victoria Mateos, Jun Ho Yi

Pageof 7

Frequent Collaborators

8 joint publications

Sonja Zweegman

5 joint publications

Christie P M Verkleij

4 joint publications

Wassilis S C Bruins

4 joint publications

Charlotte L B M Korst